Literature DB >> 293743

Enhancement of certain biological activities of muramyl dipeptide derivatives after conjugation to a multi-poly(DL-alanine)--poly(L-lysine) carrier.

L Chedid, M Parant, F Parant, F Audibert, F Lefrancier, J Choay, M Sela.   

Abstract

N-Acetylmuramyl-L-Ala-D-Glu-NH2 (muramyl dipeptide) and several of its derivatives are effective immunoactivators that can enhance nonspecific resistance to infection but can also elicit fever. In contrast, one of its stereoisomers, N-acetylmuramyl-D-Ala-D-Glu-NH2, is devoid of both these activities. Our present report demonstrates that macromolecularization of muramyl dipeptide by attachment of several units to a multi-poly(DL-Ala)-poly(L-Lys) carrier potentiates both its pyrogenic and its immunostimulant activity. This branched polymer has been extensively used as carrier to various haptens. Surprisingly, inactive N-acetylmuramyl-D-Ala-D-Glu-NH2, after conjugation under the same conditions, becomes capable of increasing nonspecific immunity although its lack of pyrogenicity is not greatly modified. Moreover, the N-acetylmuramyl-D-Ala-D-Glu--NH2 conjugate remains devoid of adjuvant, sensitizing, or eliciting activity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 293743      PMCID: PMC411905          DOI: 10.1073/pnas.76.12.6557

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  12 in total

1.  Modulation of the immune response by a synthetic adjuvant and analogs.

Authors:  L Chedid; F Audibert; P Lefrancier; J Choay; E Lederer
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

Review 2.  Biological activities of muramyl dipeptide, a synthetic glycopeptide analogous to bacterial immunoregulating agents.

Authors:  L Chedid; F Audibert; A G Johnson
Journal:  Prog Allergy       Date:  1978

3.  Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives.

Authors:  F Ellouz; A Adam; R Ciorbaru; E Lederer
Journal:  Biochem Biophys Res Commun       Date:  1974-08-19       Impact factor: 3.575

4.  [Protective effects of bacterial immunostimulants in mice infected by "Klebsiella pneumoniae" resistant to antibiotics after mutation or by plasmid transfer].

Authors:  M Parant; F Parant; L Chedid; L L Minor
Journal:  Ann Immunol (Paris)       Date:  1975-04

5.  Studies on the types of immune responses to synthetic antigens in guinea-pigs.

Authors:  Y Stupp; F Borek; M Sela
Journal:  Immunology       Date:  1966-12       Impact factor: 7.397

6.  In vivo and in vitro stimulation of nonspecific immunity by the beta-D-p-aminophenyl glycoside of N-acetylmuramyl-L-alanyl-D-isoglutamine and an oligomer prepared by cross-linking with glutaraldehyde.

Authors:  M Parant; C Damais; F Audibert; F Parant; L Chedid; E Sache; P Lefrancier; J Choay; E Lederer
Journal:  J Infect Dis       Date:  1978-09       Impact factor: 5.226

7.  Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs.

Authors:  L Chedid; M Parant; F Parant; P Lefrancher; J Choay; E Lederer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

8.  Enhancement of the neonate's nonspecific immunity to Klebsiella infection by muramyl dipeptide, a synthetic immunoadjuvant.

Authors:  M Parant; F Parant; L Chedid
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

9.  Fate of the synthetic immunoadjuvant, muramyl dipeptide (14C-labelled) in the mouse.

Authors:  M Parant; F Parant; L Chedid; A Yapo; J F Petit; E Lederer
Journal:  Int J Immunopharmacol       Date:  1979

10.  Genetic control of immune response. The dose of antigen given in aqueous solution is critical in determining which mouse strain is high responder to poly(LTyr, LGlu)-poly(LPro)--poly(LLys).

Authors:  S Jormalainen; E Mozes; M Sela
Journal:  J Exp Med       Date:  1975-05-01       Impact factor: 14.307

View more
  24 in total

1.  Peptides and proteins as drugs.

Authors:  B L Ferraiolo; L Z Benet
Journal:  Pharm Res       Date:  1985-07       Impact factor: 4.200

2.  Extraintestinal manifestations of granulomatous enterocolitis induced in rabbits by long-term submucosal administration of muramyl dipeptide emulsified with Freund's incomplete adjuvant.

Authors:  K Kuroe; Y Haga; O Funakoshi; I Mizuki; K Kanazawa; Y Yoshida
Journal:  J Gastroenterol       Date:  1996-04       Impact factor: 7.527

3.  Stimulation of resistance of immunocompromised mice by a muramyl dipeptide analog.

Authors:  Y Osada; M Mitsuyama; K Matsumoto; T Une; T Otani; H Ogawa; K Nomoto
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

4.  Stimulation of non-specific resistance to infections by synthetic immunoregulatory agents.

Authors:  M Parant; L Chedid
Journal:  Infection       Date:  1985       Impact factor: 3.553

5.  Stimulation of non-specific resistance to infections by synthetic immunoregulatory agents.

Authors:  M Parant; L Chedid
Journal:  Infection       Date:  1984 May-Jun       Impact factor: 3.553

6.  Successful immunization with a totally synthetic diphtheria vaccine.

Authors:  F Audibert; M Jolivet; L Chedid; R Arnon; M Sela
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

7.  Augmentation of protective and antibacterial activity induced by muramyl dipeptides in CBA/N defective mice with X-linked immunodeficiency for Salmonella enteritidis infection.

Authors:  K Onozuka; T Saito-Taki; M Nakano
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

8.  Polymorphonuclear leukocyte activation by a synthetic muramyl dipeptide analog.

Authors:  Y Osada; T Otani; M Sato; T Une; K Matsumoto; H Ogawa
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

9.  Activation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide.

Authors:  N P Cummings; M J Pabst; R B Johnston
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

10.  Protective effect of muramyl dipeptide analogs against infections of Pseudomonas aeruginosa or Candida albicans in mice.

Authors:  E B Fraser-Smith; T R Matthews
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.